Another evidence for the participation of ATP1A2 in ovarian serous cystadenocarcinoma pathophysiology comes from Huang et al., which revealed that the expression of ATP1A2 was higher in adjacent normal bladder tissues than in tumor tissues [29]. This evidence concerns the gene ATP1A2 and neoplasm.